Ginkgo Bioworks is a cell programming platform that uses biology to develop biotechnology products for a range of industries. Its platform offers services like enzyme engineering, strain optimization, process design and biosecurity, all made possible by proprietary automation and software. With that foundation and a team of scientists and engineers, R&D teams can navigate biology's complexities and get new products to market more quickly.
For drug discovery and more complex research workflows, BenchSci has the ASCEND platform. It's an AI-powered information retrieval system that speeds up discovery by giving researchers access to a large database and biology-specific multimodal AI that can understand experiments. With a science-first approach, ASCEND helps researchers improve the speed and quality of research, making it a good option for pharmaceutical and biotech companies.
Another good option is Genesis Therapeutics, which uses AI to accelerate the discovery of new drugs. Its GEMS platform combines deep learning and molecular simulations to predict properties and generate molecules. That lets researchers design small molecule drugs that are high potency and selective, a useful approach for finding new treatments for diseases like cancer and Alzheimer's disease.